Loading

  • June 23, 2022
  • News

What is the Recipe for a Successful ROA?

Why is Receptor Occupancy Assay so important in the development of your biologics? Receptor Occupancy Assay (ROA) by flow cytometry for quantitative assessment of the binding of a therapeutic agent to its cell-surface target, is valuable…

Read More
  • June 23, 2022
  • News

Sail safely to your new analytical method

Developing a new analytical method is just like crossing the Ocean: the Departure and Arrival are clearly marked but the journey is unknown and might change according to the weather forecast. A TRUSTED PARTNER to stay the…

Read More
  • June 23, 2022
  • News

Is your Biomarker Strategy Up-to-Date?

Research on neurological biomarkers is a very dynamic field. The recent FDA approval of a diagnostic test measuring the Amyloid-beta 1-42 / 1-40 ratio in CSF for Alzheimer's disease, or the breakthrough device status granted…

Read More
Active Biomarkers and Cynbiose sign a comarketing agreement

Active Biomarkers and Cynbiose sign a comarketing agreement

Active Biomarkers and Cynbiose are strengthening their more than 10 years collaboration with the signature of a business and comarketing agreement, offering their partners a unique combination of services to accelerate their drug developments. Check…

Read More
Active Biomarkers awarded GCLP Accreditation

Active Biomarkers awarded GCLP Accreditation

Active Biomarkers laboratories have been granted the Good Clinical Laboratory Practices (GCLP) Accreditation following an external assessment by Qualogy Ltd. Check our Press Relase for more information.  

Read More
14th EBF Open Symposium

14th EBF Open Symposium

EBF Annual Open Symposium is a landmark for bioanalytical discussions in EU. After almost two years due to the COVID pandemic, our scientists are happy to go back to Barcelona.  And we will be presenting…

Read More